|
|
|
Volumn 24, Issue 4 SUPPL. 10, 1997, Pages
|
|
Patient benefits from new treatment options and schedules for breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
METHOTREXATE;
MITOMYCIN C;
MITOXANTRONE;
PREDNISOLONE;
THIOTEPA;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
DRUG EFFICACY;
HUMAN;
MASTECTOMY;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
TREATMENT OUTCOME;
|
|
EID: 17144463511
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (15)
|
